Skip to content

Join the Assessment Waitlist

Lenire Waiting List

Lenire is now available in the United States of America following a landmark clinical study that demonstrated the safety and efficacy of Lenire. Lenire was granted De Novo approval by the United States of America Food and Drug Administration (FDA).

To ensure all Lenire patients receive the highest quality of care, we are presently working with a small group of tinnitus specialists across the United States.

Register your interest using the form to join the Assessment Waitlist.